Keywords: Myocardium, Ischemia, Ferumoxytol
Motivation: Steady-state ferumoxytol-enhanced MRI can estimate fractional myocardial blood volume. We aimed to determine the feasibility of first-pass dynamic ferumoxytol-enhanced imaging which has potential to provide complementary myocardial blood flow measurements, especially in patients contraindicated for gadolinium.
Goal(s): To achieve continuous-acquisition 3D whole-ventricle cardiac phase-resolved dynamic ferumoxytol-enhanced MRI.
Approach: The MR multitasking framework was used to reconstruct 3D cardiac phase-resolved, dynamic ferumoxytol-enhanced MRI images from 3 healthy subjects and 1 patient.
Results: Preliminary in vivo results show potential for a comprehensive assessment of myocardial perfusion and for detecting small perfusion defects.
Impact: We proposed a dynamic ferumoxytol-enhanced cardiac MRI technique which has 3D whole-ventricle coverage and is non-ECG gated and free-breathing. It may provide the groundwork for a comprehensive assessment of myocardial blood flow and blood volume in a single acquisition.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords